Qube Research & Technologies LTD Graphite Bio, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.82 - $3.59 $20,050 - $25,524	7,110 Added 35.56%	27,103 $89,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $6,627 - $9,964	2,350 Added 13.32%	19,993 $63,000
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $37,756 - $92,272	17,643 New	17,643 $49,000
Q3 2021 Nov 12, 2021	SELL	$15.81 - $28.39 $232,407 - $417,333	-14,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.5 - $30.73 $271,950 - $451,731	14,700 New	14,700 $452,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.